Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

moxifloxacin has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(benzyloxycarbonylleucyl-leucyl-leucine aldehyde)		Trials
(benzyloxycarbonylleucyl-leucyl-leucine aldehyde)		Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde)
3,1575521,6902,47331,057

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50)
Proteasome subunit beta type-11Homo sapiens (human)1.9893
Calpain-9Homo sapiens (human)9.88
Proteasome subunit alpha type-7Homo sapiens (human)1.9893
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus3.9
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.8999
AromataseHomo sapiens (human)0.044
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)0.5
Proteasome subunit beta type-1Homo sapiens (human)1.0853
Proteasome subunit alpha type-1Homo sapiens (human)1.9893
Proteasome subunit alpha type-2Homo sapiens (human)1.9893
Proteasome subunit alpha type-3Homo sapiens (human)1.9893
Proteasome subunit alpha type-4Homo sapiens (human)1.9893
Proteasome subunit beta type-8Homo sapiens (human)1.9893
Proteasome subunit beta type-9Homo sapiens (human)1.9893
Proteasome subunit alpha type-5Homo sapiens (human)1.9893
Proteasome subunit beta type-4Homo sapiens (human)1.9893
Proteasome subunit beta type-6Homo sapiens (human)1.9893
Proteasome subunit beta type-5Homo sapiens (human)0.6088
Proteasome subunit beta type-10Homo sapiens (human)1.9893
Proteasome subunit beta type-3Homo sapiens (human)1.9893
Proteasome subunit beta type-2Homo sapiens (human)2.0443
Proteasome subunit alpha type-6Homo sapiens (human)1.9893
Proteasome subunit alpha-type 8Homo sapiens (human)1.9893
Proteasome subunit beta type-7Homo sapiens (human)1.9893

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

1 other study(ies) available for moxifloxacin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde

ArticleYear
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021